EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Comparative Proteomic Analysis of Type 2 Diabetic versus Non-Diabetic Vitreous Fluids

Abdulaziz H Alanazi, Shengshuai Shan iD, S Priya Narayanan iD, Payaningal R Somanath iD

Life · 16.07.2024 · 14 (7) · 883

DOI: 10.3390/life14070883 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Life, online erschienen am 16.07.2024. Verfasst von Abdulaziz H Alanazi und 3 weiteren Autor:innen. Beteiligte Einrichtung: Clinical and Experimental Therapeutics, University of Georgia, Augusta, GA 30912, USA. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NEI NIH HHS, NIH HHS, NCATS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Diabetic retinopathy (DR) is a leading cause of vision loss, with complex mechanisms. The study aimed to comprehensively explore vitreous humor of diabetic and non-diabetic individuals, paving the way for identifying the potential molecular mechanisms underlying DR.

Methods

Vitreous samples from type 2 diabetic and non-diabetic subjects, collected post-mortem, were analyzed using liquid chromatography–mass spectrometry. Pathway enrichment and gene ontology analyses were conducted to identify dysregulated pathways and characterize protein functions.

Results

Pathway analysis revealed dysregulation in multiple metabolic and signaling pathways associated with diabetes, including glycerolipid metabolism, histidine metabolism, and Wnt signaling. Gene ontology analysis identified proteins involved in inflammation, immune response dysregulation, and calcium signaling. Notably, proteins such as Inositol 1,4,5-trisphosphate receptor type 2 (ITPR2), Calcium homeostasis endoplasmic reticulum protein (CHERP), and Coronin-1A (CORO1A) were markedly upregulated in diabetic vitreous, implicating aberrant calcium signaling, inflammatory responses, and cytoskeletal reorganization in DR.

Conclusions

Our study provides valuable insights into the intricate mechanisms underlying DR and highlights the significance of inflammation, immune dysregulation, and metabolic disturbances in disease progression. Identification of specific proteins as potential biomarkers underscores the multifactorial nature of DR. Future research in this area is vital for advancing therapeutic interventions and translating findings into clinical practice.

Schlagwörter

Stichwörter der Autor:innen

diabetesgene enrichment analysisinflammationproteomicsvitreous

Autor:innen und Institutionen

  • Clinical and Experimental Therapeutics, University of Georgia, Augusta, GA 30912, USA.
  • Vision Discovery Institute, Augusta University, Augusta, GA 30912, USA.
  • Department of Clinical Practice, College of Pharmacy, Northern Border University, Rafha 91531, Saudi Arabia.

ORCID-Profile: Shengshuai Shan, S Priya Narayanan, Payaningal R Somanath

Förderung

  • NEI NIH HHS
  • NIH HHS
  • NCATS NIH HHS
  • National Institutes of Health
  • National Center for Advancing Translational Sciences (NCATS)

Zitieren

APA

Alanazi, A. H., Shan, S., Narayanan, S. P., & Somanath, P. R. (2024). Comparative Proteomic Analysis of Type 2 Diabetic versus Non-Diabetic Vitreous Fluids. Life, 14(7), 883. https://doi.org/10.3390/life14070883

Vancouver

Alanazi AH, Shan S, Narayanan SP, Somanath PR. Comparative Proteomic Analysis of Type 2 Diabetic versus Non-Diabetic Vitreous Fluids. Life. 2024;14(7):883. doi:10.3390/life14070883

BibTeX
@article{Alanazi2024,
  author = {Alanazi, Abdulaziz H and Shan, Shengshuai and Narayanan, S Priya and Somanath, Payaningal R},
  title = {Comparative Proteomic Analysis of Type 2 Diabetic versus Non-Diabetic Vitreous Fluids},
  journal = {Life},
  year = {2024},
  volume = {14},
  number = {7},
  pages = {883},
  doi = {10.3390/life14070883}
}
Kostenlos starten →